Mereo BioPharma
Funding deals worth up to $33m announcedMereo BioPharma
Additional ASTEROID data supports progressionMereo BioPharma
Oncologie takes global licence to NaviMereo BioPharma
Underappreciated and undervaluedMereo BioPharma
Setrusumab ready to advance into pivotal studiesMereo BioPharma
Setrusumab set to advanceMereo BioPharma
Entering an important 12 month periodMereo BioPharma
Accelerated approval path for NAVIMereo BioPharma
Encouraging interim BPS-804 data in OIMereo BioPharma
Focus shifts back to imminent data